Delivery Order SPE2DR25D1106-SPE2DR26FHZ3E
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,121.46 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) with an ultimate completion date of November 17, 2025. The contract employs firm fixed-price pricing and was competitively awarded without any set-aside designation. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency (DLA) awarded a $3,983.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a 90-count quantity. This is a non-set-aside competitive award with an ultimate completion date of November 6, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,143.92 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count bottles) under a firm fixed price contract. This non-competitive delivery order, issued on November 3, 2025, with completion expected by November 4, 2025, represents a small-value pharmaceutical procurement fulfilling federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets in a 90-count quantity. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $28,009.13 and is scheduled for completion by September 10, 2025. The contract represents a single line item fulfillment under AmerisourceBergen's existing pharmaceutical supply vehicle with DLA, with performance to occur...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,436.44 firm fixed-price delivery order contract (SPE2DX15D3015|SPE2DX24F0EN0) to AmerisourceBergen Drug Corp for the supply of 4,563,434,205 units of Losartan-HCTZ 50-12.5 mg tablets. This delivery order is part of a larger $999,999,999 indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets in a 90-count quantity. This firm fixed-price delivery order, valued at $19,522.44, represents a non-competitive, non-set-aside award with an ultimate completion date of November 4, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,152.20 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and was issued on October 28, 2025, with an ultimate completion date of October 29, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order functions as a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,138.05 to AmerisourceBergen Drug Corp for the supply of Losartan-HCZ 100-12.5 mg tablets in a 90-day supply. This competitively awarded, firm fixed-price delivery order was issued on November 12, 2025, with an ultimate completion date of November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Losartan-HCTZ 100-12.5 mg tablets (90-count) on November 12, 2025, with a ceiling value of $1,980.19 and an ultimate completion date of November 13, 2025. This firm fixed price delivery order represents a routine pharmaceutical supply transaction under a non-competitive set-aside arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $2,050.77 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count packaging). The contract carries a firm fixed price structure with no set-aside designation and is scheduled for completion by November 17, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FHZ3EDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,073.75 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count supply). This contract, awarded on November 12, 2025, with an ultimate completion date of November 13, 2025, was competitively awarded with no set-aside designation and carries firm fixed pricing terms. The delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle extending through December 2026 that enables the company to supply medications and medical supplies globally to support military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company maintains extensive experience fulfilling DLA medical supply requirements through competitively awarded delivery orders covering a broad spectrum of pharmaceutical products including brand-name and generic medications, vaccines, and specialty medical supplies. This particular delivery order represents a routine transaction within the company's ongoing support of federal healthcare operations through its Troop Support Medical prime contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 11/12/25 |